Literature DB >> 14707030

Contribution of nitric oxide produced by inducible nitric oxide synthase to vascular responses of mesenteric arterioles in streptozotocin-diabetic rats.

Tomohisa Ishikawa1, Fumika Kohno, Ryosuke Kawase, Yuri Yamamoto, Koichi Nakayama.   

Abstract

1. The functional changes in mesenteric arterioles of streptozotocin-induced diabetes were investigated by intravital microscopy. The mesentery was exteriorized from anesthetized rats, spread in a chamber, and superfused with Tyrode solution. All drugs tested were applied to the superfusing Tyrode solution. 2. Compared with age-matched controls, the diabetic rats showed enhanced vascular sensitivity to phenylephrine, an alpha(1)-adrenoceptor agonist. The preincubation of the mesentery with N(G)-nitro-l-arginine (l-NNA), a nitric oxide synthase (NOS) inhibitor, shifted the phenylephrine-concentration-response curves to the left in both the diabetic and control rats. Even in the presence of l-NNA, the sensitivity to phenylephrine was higher in the diabetic rats than in the control. 3. Acetylcholine relaxed the mesenteric arterioles in both groups, but to a significantly greater extent in the control than in the diabetic rats. However, the l-NNA-induced constriction of arterioles did not differ significantly between the groups. In contrast, the amplitude of the constrictions of mesenteric arterioles induced by S-ethylisothiourea, an inducible NOS (iNOS) inhibitor, was significantly greater in the diabetic rats than in the control. 4. Immunostaining of the mesentery with a specific antibody for iNOS revealed iNOS in the microvessels of only the diabetic rats. 5. These results suggest that constrictor responses to alpha(1)-adrenoceptor stimulation are sensitized in the mesenteric arterioles of STZ-diabetic rats, and that iNOS expressed in the arteriolar smooth muscle plays a role in suppressing the basal tone and the reactivity of the arterioles in STZ-diabetic rats.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14707030      PMCID: PMC1574198          DOI: 10.1038/sj.bjp.0705611

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  45 in total

1.  Reversal effect of thyroxine on altered vascular reactivity in diabetic rats.

Authors:  Y Takiguchi; N Satoh; H Hashimoto; M Nakashima
Journal:  J Cardiovasc Pharmacol       Date:  1989-04       Impact factor: 3.105

Review 2.  Role of oxidative stress in development of complications in diabetes.

Authors:  J W Baynes
Journal:  Diabetes       Date:  1991-04       Impact factor: 9.461

3.  Effects of porcine galanin on the mesenteric microcirculation and arteriolar smooth muscle in the rat.

Authors:  K Nakayama; N Watanabe; T Yamazawa; N Takeshita; Y Tanaka; N Yanaihara
Journal:  Eur J Pharmacol       Date:  1991-01-25       Impact factor: 4.432

4.  Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor.

Authors:  G M Rubanyi; P M Vanhoutte
Journal:  Am J Physiol       Date:  1986-05

5.  Alterations in the baroreceptor reflex control of heart rate in streptozotocin diabetic rats.

Authors:  K S Chang; D D Lund
Journal:  J Mol Cell Cardiol       Date:  1986-06       Impact factor: 5.000

6.  Endothelium-dependent relaxation and noradrenaline sensitivity in mesenteric resistance arteries of streptozotocin-induced diabetic rats.

Authors:  P D Taylor; A L McCarthy; C R Thomas; L Poston
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

7.  Selective impairment of hindquarters vasodilator responses to bradykinin in conscious Wistar rats with streptozotocin-induced diabetes mellitus.

Authors:  R J Kiff; S M Gardiner; A M Compton; T Bennett
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

8.  Free radicals mediate endothelial cell dysfunction caused by elevated glucose.

Authors:  B Tesfamariam; R A Cohen
Journal:  Am J Physiol       Date:  1992-08

9.  Influence of the endothelium on contractile responses of arteries from diabetic rats.

Authors:  K H Harris; K M MacLeod
Journal:  Eur J Pharmacol       Date:  1988-08-09       Impact factor: 4.432

10.  Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes.

Authors:  R Bucala; K J Tracey; A Cerami
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

View more
  5 in total

1.  Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes.

Authors:  I Vareniuk; I A Pavlov; I G Obrosova
Journal:  Diabetologia       Date:  2008-09-19       Impact factor: 10.122

2.  Genetic ablation of calcium-independent phospholipase A(2)beta causes hypercontractility and markedly attenuates endothelium-dependent relaxation to acetylcholine.

Authors:  Hans H Dietrich; Dana R Abendschein; Sung Ho Moon; Neema Nayeb-Hashemi; David J Mancuso; Christopher M Jenkins; Kevin M Kaltenbronn; Kendall J Blumer; John Turk; Richard W Gross
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-09       Impact factor: 4.733

3.  Na+,K+-ATPase is modulated by angiotensin II in diabetic rat kidney--another reason for diabetic nephropathy?

Authors:  Andrea Fekete; Klara Rosta; Laszlo Wagner; Agnes Prokai; Peter Degrell; Eva Ruzicska; Edit Vegh; Miklos Toth; Katalin Ronai; Krisztina Rusai; Aniko Somogyi; Tivadar Tulassay; Attila J Szabo; Agota Ver
Journal:  J Physiol       Date:  2008-09-25       Impact factor: 5.182

4.  L-arginine supplementation normalizes bone turnover and preserves bone mass in streptozotocin-induced diabetic rats.

Authors:  P Pennisi; G Clementi; A Prato; T Luca; G Martinez; R A Mangiafico; I Pulvirenti; F Muratore; C E Fiore
Journal:  J Endocrinol Invest       Date:  2009-05-05       Impact factor: 4.256

5.  Endothelial dysfunction in mice with streptozotocin-induced type 1 diabetes is opposed by compensatory overexpression of cyclooxygenase-2 in the vasculature.

Authors:  Carmela Nacci; Mariela Tarquinio; Leonarda De Benedictis; Annamaria Mauro; Addolorata Zigrino; Maria Rosaria Carratù; Michael J Quon; Monica Montagnani
Journal:  Endocrinology       Date:  2008-10-09       Impact factor: 4.736

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.